Synapse - David Straus

Results (361)

Chemotherapy only for localized Hodgkin lymphoma

Journal Article

Straus, D. J.
Journal of Internal Medicine (2011)

Risk-adapted therapy using biopsy confirmation of abnormal interim FDG-PET for patients with advanced stage diffuse large B cell lymphoma (DLBCL), and exploratory evaluation of FLT-PET

Meeting Abstract

Moskowitz, C. H.; Schoder, H.; Hamlin, P. A.; Gerecitano, J. F.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Noy, A.; Palomba, M.; Portlock, C. S.; more...
Annals of Oncology (2011)

Fulltext@MSK | Save

Updated results of a phase II trial of bendamustine in relapsed and refractory Hodgkin lymphoma

Meeting Abstract

Moskowitz, A. J.; Hamlin, P.; Gerecitano, J.; Horwitz, S.; Matasar, M.; Noy, A.; Palomba, M. L.; Portlock, C.; Straus, D.; Graustein, T.; more...
Annals of Oncology (2011)

Fulltext@MSK | Save

Recent results of treatment of early stage Hodgkin lymphoma: Risk-adapted approaches

Journal Article

Straus, D. J.
Leukemia and Lymphoma (2011)

Fulltext@MSK | Save

Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: Pretreatment prognostic factors and interim PET

Journal Article

Straus, D. J.; Johnson, J. L.; LaCasce, A. S.; Bartlett, N. L.; Kostakoglu, L.; Hsi, E. D.; Schoder, H.; Hall, N. C.; Jung, S. H.; Canellos, G. P.; more...
Blood (2011)

Fulltext@MSK | Save

Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-hodgkin lymphoma

Journal Article

Gerecitano, J.; Portlock, C.; Hamlin, P.; Moskowitz, C. H.; Noy, A.; Straus, D.; Schulman, P.; Dumitrescu, O.; Sarasohn, D.; Pappanicholaou, J.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Necrobiotic xanthogranuloma associated with immunoglobulin m paraproteinemia in a patient with waldenström macroglobulinemia

Journal Article

Balagula, Y.; Straus, D. J.; Pulitzer, M. P.; Lacouture, M. E.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Interim results of phase II trial of pegylated liposomal doxorubicin (PLD) followed by bexarotene in advanced cutaneous T-cell lymphoma (CTCL)

Meeting Abstract

Straus, D. J.; Duvic, M.; Horwitz, S. M.; Hymes, K. B.; Goy, A.; Hernandez-Ilizaliturri, F. J.; Feldman, T.; Wegner, B.; Myskowski, P.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Final results of a phase II study of sequential R-CHOP and yttrium-90 ibritumomab tiuxetan (RIT) for elderly high risk patients with untreated diffuse large B-cell lymphoma (DLBCL)